The Cure Parkinson's Trust's (CPT) Director of Research & Development, Dr Richard Wyse, was invited as chair of the recent two-day World CNS Summit in Boston, USA. Now in it’s 7th year, the World CNS Summit is considered to be the premier industry-specific conference targeting neurodegenerative diseases, and CPT was delighted to have been involved in such a significant way.  

This unique and highly prestigious summit focuses on brand new drug discovery and development aimed to deliver substantial improvements in the treatment of a range of major diseases of the central nervous system (CNS), including Parkinson’s. 

Organised by Hanson Wade, the CNS Summit, attracted 34 outstanding speakers from around the world. They presented their latest discoveries to a very large expert audience and topics included recent relevant discoveries in physiology, pharmacology, new drug developments, biomarkers, important cutting edge developments in brain imaging, and progress with on-going clinical trials.

Find out more about this influential summit here.